The pathology involved in the development of Alzheimer’s disease comprises increased levels of t-tau and p-tau in the CSF due to their release from injured and dying neurons and the polymerization of soluble Aβ to form insoluble plaques in the brain [130]. This evidence concerns the gene MAPT and Alzheimer disease.